Want to see FR:GNFT full AI Analyst Report?
Compare Genfit (GNFT) vs. Competitors
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| FR:GNFTGenfit | EUR 10.86 | EUR 541.90M | -5.32 | 198.35% | Moderate Buy | FR:GNFT | ||||
| FR:ABVXAbivax SA | EUR 79.05 | EUR 6.92B | -16.78 | -12.65% | Moderate Buy | FR:GNFT vs FR:ABVX | ||||
| FR:IVAInventiva | EUR 3.18 | EUR 760.35M | -6.00 | -6.74% | ― | FR:GNFT vs FR:IVA | ||||
| FR:POXELPoxel SA | EUR 0.17 | EUR 8.87M | -0.43 | -48.11% | ― | FR:GNFT vs FR:POXEL | ||||
| FR:ALVALValbiotis SA | EUR 0.63 | EUR 22.31M | -2.13 | -11.92% | ― | FR:GNFT vs FR:ALVAL | ||||
| FR:MAATMaaT Pharma | EUR 1.02 | EUR 19.20M | -0.53 | -75.70% | ― | FR:GNFT vs FR:MAAT |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| FR:GNFT | Genfit | 10.86 | 7.31 | 205.92% | |
| FR:ABVX | Abivax SA | 79.05 | -4.25 | -5.10% | |
| FR:IVA | Inventiva | 3.18 | -0.34 | -9.66% | |
| FR:POXEL | Poxel SA | 0.17 | -0.17 | -50.30% | |
| FR:ALVAL | Valbiotis SA | 0.63 | -0.01 | -0.95% | |
| FR:MAAT | MaaT Pharma | 1.02 | -3.25 | -76.16% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts